Your browser doesn't support javascript.
loading
Auricular acupressure for insomnia in hemodialysis patients: study protocol for a randomized controlled trial.
Wu, Yuchi; Yang, Lihong; Li, Lingli; Wu, Xiuqing; Zhong, Zhicong; He, Zhiren; Ma, Hongyan; Wang, Lixin; Lu, Zhaoyu; Cai, Cun; Zhao, Daixin; Meng, Xiangxin; Qi, Airong; Yang, Aicheng; Su, Guobin; Guo, Xinfeng; Liu, Xusheng; Zou, Chuan; Lin, Qizhan.
Afiliação
  • Wu Y; Hemodialysis Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, People's Republic of China.
  • Yang L; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Li L; Hemodialysis Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, People's Republic of China.
  • Wu X; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Zhong Z; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • He Z; Hemodialysis Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, People's Republic of China.
  • Ma H; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Wang L; Hemodialysis Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, People's Republic of China.
  • Lu Z; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Cai C; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Zhao D; Hemodialysis Department, Guangzhou Charity Hospital, Guangzhou, People's Republic of China.
  • Meng X; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Qi A; Hemodialysis Department, Guangzhou Charity Hospital, Guangzhou, People's Republic of China.
  • Yang A; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Su G; Hemodialysis Department, Guangzhou Charity Hospital, Guangzhou, People's Republic of China.
  • Guo X; Hemodialysis Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, People's Republic of China.
  • Liu X; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Zou C; Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Lin Q; Hemodialysis Department, Guangzhou HEMC (Higher Education Mega Center) Hospital, Guangzhou, People's Republic of China.
Trials ; 19(1): 171, 2018 Mar 07.
Article em En | MEDLINE | ID: mdl-29514705
BACKGROUND: Patients on maintenance hemodialysis (MHD) frequently complain of insomnia. Poor sleep quality impairs their quality of life and adversely affects long-term outcome. Previously we applied auricular acupressure therapy (AAT) for MHD patients with insomnia and yielded favorable results. AAT probably improves sleep quality by stimulating the vagus nerve and inhibiting sympathetic overactivity. However, the efficacy of AAT for insomnia in this population is still lacking. The proposed randomized controlled trial (RCT) will evaluate the efficacy and safety of AAT for improvement of sleep quality in MHD patients with insomnia. METHODS/DESIGN: The proposed study is a multi-center, double-blind (participants and assessors), parallel-group RCT. A total of 112 participants with insomnia will be recruited from six hemodialysis centers in Guangzhou, China, and randomly allocated in a 1:1 ratio to receive auricular acupressure on either active points (AA group) or control points (points irrelevant to insomnia management, SAA group). The treatment will last for 8 weeks prior to a follow-up period of 12 weeks. Evaluation by blinded assessors at baseline, at 8 weeks (end of treatment) as well as at 4-week, 8-week and 12-week follow-ups (after intervention) will include Pittsburgh Sleep Quality Index (PSQI) scores and average weekly dose of hypnotics. The primary endpoint is clinical response rate (percentage of participants who reach a reduction of PSQI global score ≥ 3 in each group) at 8 weeks from baseline. Secondary endpoints include the changes in PSQI scores over time from baseline, as well as the changes in weekly dose of hypnotics. DISCUSSION: This paper describes the rationale and design of a double-blind RCT that aims to determine the efficacy and safety of AAT for insomnia of hemodialysis patients. If successful, this project will provide evidence of the efficacy and safety of AAT for insomnia of hemodialysis patients. TRIAL REGISTRATION: ClinicalTrials.gov , Identifier: NCT03015766 . Registered on 22 December 2016.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Sono / Diálise Renal / Acupressão / Distúrbios do Início e da Manutenção do Sono / Nefropatias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Aspecto: Patient_preference Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Trials Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Sono / Diálise Renal / Acupressão / Distúrbios do Início e da Manutenção do Sono / Nefropatias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Aspecto: Patient_preference Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Trials Ano de publicação: 2018 Tipo de documento: Article